FDA clears FAAH inhibitors for trials, says it will help with labeling for OTC naloxone

FDA finds drugs under investigation in the U.S. related to French BIA 10‐2474 drug do not pose similar safety risks

Source: The Brown University Child and Adolescent Psychopharmacology Update - August 28, 2016 Category: Psychiatry Tags: From the FDA Source Type: research